Purchase Order 36C26024P0378
Award Date 3/5/24
Potential Completion Date 4/5/24
Potential Value $43K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Vernonburg, GA 31406, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $42,708 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract is for the delivery of RYDAPT 25MG capsules and is set to be completed by March 5, 2024. There is no set-aside designation for this award. Broughton Pharmaceuticals is an established federal contractor, having provided a range of pharmaceutical products and medical supplies to...
- The U.S. Department of Defense's Bureau of Medicine and Surgery awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The $150,000 contract is for the delivery of pharmaceutical products, including medications like RYDAPT, Novolog insulin, Carimune, and oncological drugs, as well as personal protective equipment such as N95 masks and disinfectant wipes. This BPA call is part of a...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract, valued at $80,000.00, is for the emergency procurement of pharmacy drugs to address back-order issues. The award has an ultimate completion date of October 1, 2022. Broughton Pharmaceuticals is an experienced federal contractor, having secured multiple contract awards from the VA and...
- This federal contract award, valued at $75,000.00, was issued by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract is a Blanket Purchase Agreement (BPA) call for the delivery of various pharmaceuticals, such as Amidate vials, Adrenaline 30ML MDV, and Atropine SYR, to support military healthcare operations. The contract has a firm fixed-price pricing type and an ultimate completion date of June 14,...
- This is a $382,300.88 firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Biocryst Pharmaceuticals Inc., a biotechnology company that specializes in developing drugs for rare diseases. The contract is for the bulk order of ORLADEYO, a drug used to treat hereditary angioedema, to support veteran healthcare. The contract is not set aside and is part of Biocryst's Federal Supply Schedule (FSS)...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 15 to Woods International LLC, a minority-owned, veteran-owned, and service-disabled veteran-owned small business based in Riverview, Florida. The contract is for the delivery of Pyridostigmine Bromide 180mg SA Tab, a pharmaceutical product, with a ceiling value of $18,125.00 and a completion date of June 19, 2025. The contract...
- This federal contract award was made by the Veterans Integrated Service Network 20 (VISN 20), a civilian agency, to Biocryst Pharmaceuticals Inc., a biotechnology company specializing in rare disease pharmaceuticals. The $379,939.32 firm fixed-price delivery order contract is for the supply of BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO), a medication used to treat hereditary angioedema. The contract has an ultimate completion date of September 30, 2025 and was awarded on October 1, 2024. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,693.94 fixed-price contract is for the delivery of Vyndamax 61 mg capsules, a medication used to treat a specific condition. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which provides comprehensive global pharmaceutical support to...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This firm fixed-price delivery order, valued at $13,846.97, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $14,592.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract represents a non-set-aside, competitively awarded procurement with an ultimate completion date of January 27, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...